On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.
Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...